Pfizer Inc

NYSE: PFE
$26.52
-$0.21 (-0.8%)
Real Time Data Delayed 15 Min.

PFE Articles

The 2017 annual meeting of the American Society of Clinical Oncology (ASCO) runs from June 2 to June 6. The following companies have signaled that they will be presenting data, or data will be...
A new Deutsche Bank research report focuses on the big capitalization pharmaceutical stocks and the upcoming catalysts and news flow they have for the rest of 2017.
The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly upward.
These are the top 10 Sell equivalent ratings seen from analysts during the week of May 15 to May 19, 2017 -- plus a bonus that may as well have been a downgrade to Sell.
UnitedHealth, Nike, Pfizer, and Wal-Mart led the DJIA to a modest decline Tuesday.
The the top analyst upgrades, downgrades and other research calls from Tuesday include AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy and Yum Brands.
Credit Suisse provided its outlook for several large-cap pharmaceutical stocks Monday morning. The analyst has three top picks to consider.
With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it as the industry punching bag.
Sangamo Therapeutics saw its shares skyrocket early on Thursday after a critical business update.
The April 28 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly downward.
Pfizer reported mixed first-quarter financial results before the markets opened on Tuesday.
24/7 Wall St. has put together a preview of the Dow Jones Industrial Average companies scheduled to report their quarterly results this week.
24/7 Wall St. has put together a preview of Apple, Facebook, Pfizer and some of the other top companies reporting their latest results in the coming week.
The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The March 31 short interest data have been compared with the previous figures, and short interest decreased in most of these selected pharmaceutical stocks.